e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pulmonary arterial hypertension and other pulmonary vascular diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NT-proBNP correlation with disease severity in PAH-SSc versus IPAH
S. Mathai, H. Champion, A. Zaiman, R. Girgis, P. Hassoun (Baltimore, MD, United States Of America)
Source:
Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Session:
Pulmonary arterial hypertension and other pulmonary vascular diseases
Session type:
E-Communication Session
Number:
1420
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mathai, H. Champion, A. Zaiman, R. Girgis, P. Hassoun (Baltimore, MD, United States Of America). NT-proBNP correlation with disease severity in PAH-SSc versus IPAH. Eur Respir J 2008; 32: Suppl. 52, 1420
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
NT-proBNP correlates with RVEF in patients suffering from pulmonary arterial hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 110s
Year: 2004
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006
NT-proBNP variation in stable pulmonary arterial hypertension patients.
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Automatic quantitative fibrosis scores at baseline is a predictor of progression in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 373s
Year: 2007
Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Microalbuminuria in patients with COPD: prevalence and correlations with pulmonary parameters
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
Relationship between pharmacotherapy and severity of disease in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007
Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (1) 00074-2016; 10.1183/23120541.00074-2016
Year: 2017
Is there any relationship between the duration to diagnosis of COPD and severity of the disease?
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
RV/TLC ratio as an independent prognostic indicator in idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Degree of LVEF with respect to severity of COPD
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Functional and prognostic significance of relationship between VC and TLC in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005
A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease
Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017
Year: 2018
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 150s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept